A Systematic Review of Clinical Outcomes in Laparoscopic versus Robotic Donor Nephrectomy
Abstract
Living donor kidney transplantation remains the preferred treatment for end-stage renal disease because it provides superior long-term outcomes compared with dialysis. The increasing use of minimally invasive techniques, particularly Laparoscopic Donor Nephrectomy (LDN) and Robotic Donor Nephrectomy (RDN), has prompted comparisons of their perioperative performance and donor outcomes. This study systematically reviewed evidence comparing postoperative renal function, hospital length of stay, perioperative parameters, and postoperative complications between LDN and RDN. A systematic review following PRISMA guidelines searched PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar for comparative studies published between 2010 and 2025. Methodological quality was assessed using the Newcastle–Ottawa Scale and the JBI Critical Appraisal Checklist. Ten studies met the inclusion criteria and were synthesized qualitatively. The evidence indicates that RDN and LDN produce comparable postoperative renal function, including stable estimated glomerular filtration rate (eGFR) and serum creatinine levels. Several studies reported shorter hospital stays, lower early postoperative pain scores, and faster recovery with RDN, although robotic procedures required longer operative times during early implementation. Complication rates were generally low and similar between techniques. Overall, both LDN and RDN are feasible and safe minimally invasive approaches for living donor nephrectomy. However, variations in study design, institutional experience, and outcome reporting limit definitive conclusions regarding the superiority of either technique, highlighting the need for standardized high-quality comparative studies.
Keywords: complications; hospital stay; laparoscopic donor nephrectomy; renal function; robotic donor nephrectomy.
Introduction
Kidney transplantation represents the definitive therapeutic intervention for individuals with end-stage renal disease (ESRD), demonstrating superior long-term survival and quality-of-life outcomes compared with dialysis modalities (Matas & Rule, 2022; Ortiz et al., 2025). The success of living donor kidney transplantation, however, depends not only on recipient graft outcomes but also on the preservation of donor safety and postoperative well-being during nephrectomy procedures (Chan et al., 2025; Napoli et al., 2024). Consequently, surgical techniques for donor nephrectomy continue to evolve toward minimally invasive approaches that reduce perioperative morbidity while maintaining graft integrity and functional outcomes (Plage et al., 2020).
Since its introduction in the 1990s, laparoscopic donor nephrectomy (LDN) has become the standard minimally invasive approach for living kidney procurement because of its association with reduced postoperative pain, shorter hospitalization, improved cosmetic outcomes, and faster recovery compared with open surgery, without compromising graft function (Wang et al., 2020). The technique also demonstrates acceptable intraoperative safety profiles characterized by low conversion rates and limited transfusion requirements (Zaytoun et al., 2021). Nevertheless, conventional laparoscopy remains technically demanding, particularly in complex donor anatomy and prolonged procedures, due to limitations in instrument dexterity, ergonomics, and depth perception.
Technological advancements in minimally invasive surgery have facilitated robotic donor nephrectomy (RDN), which incorporates three-dimensional visualization, articulated instrumentation, enhanced precision, and improved operator ergonomics (Munoz Abraham et al., 2025; Serni et al., 2021). These features may reduce surgeon fatigue and improve technical performance. Previous studies suggest robotic systems may stabilize perioperative performance and facilitate learning in experienced transplant centers (Khajeh et al., 2023; Pham et al., 2026).
Despite increasing clinical utilization of RDN, comparative evidence remains heterogeneous. Some studies report shorter hospitalization and lower postoperative pain with robotic approaches, while operative duration, warm ischemia time, and perioperative efficiency remain inconsistent across institutions and experience levels (Khajeh et al., 2023; Musquera et al., 2025). Acquisition costs, maintenance, infrastructure, and workforce training also influence implementation (Boyar et al., 2021; Hinojosa-Gonzalez et al., 2023; Serni et al., 2021).
Earlier comparative reviews primarily emphasized technical variables such as operative time, blood loss, and conversion rates. Donor-centered outcomes—including postoperative renal function, hospital length of stay, and standardized complication profiles—were often secondary. This review therefore provides an updated donor-centered synthesis of evidence published from 2010 to 2025, integrating contemporary robotic implementation experience and operational considerations.
The study aims to systematically compare LDN and RDN with emphasis on postoperative renal function, hospital length of stay, and perioperative and postoperative complications, while clarifying the evidentiary position of RDN and identifying priorities for standardized high-quality research.
Methods
Study Design
This systematic review comparatively evaluated clinical outcomes between LDN and RDN in living kidney donors. It focused on postoperative renal function, hospital length of stay, and perioperative and postoperative complications. The methodology followed PRISMA guidelines. Owing to heterogeneity in design, definitions, institutional protocols, and reporting formats, the review used structured narrative synthesis rather than quantitative meta-analysis; no pooled effect estimates or forest plots were generated.
Literature Search Strategy
A comprehensive search was conducted in PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar between January and March 2025, with the final search completed on 28 March 2025. Search terms combined LDN/RDN terminology with renal function, hospital stay, complications, and comparative-study terms using Boolean operators. Studies published from 2010 to 2025 were eligible. The first 200 Google Scholar results sorted by relevance were screened, and duplicates were removed.
Study Selection and Eligibility Criteria
Two reviewers independently screened titles, abstracts, and full texts. Disagreements were resolved by discussion or a third reviewer. Eligible studies directly compared LDN and RDN in living adult kidney donors, reported at least one donor-centered outcome, used prospective or retrospective comparative designs, and were published in English from 2010 to 2025. Non-comparative studies, case reports, abstracts, editorials, reviews without patient-level comparative data, pediatric or non-living donor procedures, insufficient reports, duplicates, and overlapping datasets were excluded.
Data Extraction
Two reviewers used a standardized extraction form to collect author, year, country, study design, sample size, donor demographics, operative time, estimated blood loss, warm ischemia time, postoperative serum creatinine and eGFR, hospital stay, complications, and principal findings. Discrepancies were resolved through discussion and verification against original articles.
Quality Appraisal
Methodological quality was assessed independently using the Newcastle–Ottawa Scale for cohort and observational comparative studies and the JBI Critical Appraisal Checklist where appropriate. Selection, group comparability, outcome assessment, and adequacy of follow-up were evaluated, with scoring differences resolved by consensus.
Data Synthesis and Analysis
Because of heterogeneity, results were synthesized narratively across three domains: postoperative renal function, length of hospital stay, and perioperative/postoperative complications. Descriptive tables and thematic interpretation were used to identify similarities, differences, and emerging cross-study patterns.
Result and Discussion
Search Strategy and Study Selection
The database search identified 400 records. After 80 records were removed before screening, 320 titles and abstracts were assessed and 200 were excluded. Of 120 full-text reports sought, 10 were unavailable. Among 110 reports assessed for eligibility, 83 were excluded for irrelevance, inadequate publication quality, or limited accessibility. Ten studies were ultimately included in the qualitative synthesis.
PRISMA Flow Diagram
The PRISMA 2020 diagram documents identification, screening, eligibility, and inclusion. It shows the contribution of each database, removal of duplicate and automated exclusions, title/abstract screening, full-text retrieval, reasons for exclusion, and final inclusion of 10 studies.
Quality Assessment and Risk of Bias
Most included studies showed moderate methodological quality and relatively low risk of bias in outcome reporting. Nevertheless, retrospective single-center designs, selection bias, differences in surgeon expertise, learning curves, and perioperative protocols limited external generalizability and contributed to clinical heterogeneity.
| Author (Year) | Country | Study Design | Population | Intervention | Findings |
|---|---|---|---|---|---|
| Zeuschner et al., 2020 | Germany | Retrospective cohort | Living kidney donors | RDN vs LDN | Comparable perioperative safety and renal function; low and equivalent complications; no significant long-term graft-function differences. |
| Windisch et al., 2022 | Belgium | Retrospective comparative | Adult living donors | RDN vs hand-assisted LDN | Longer operative time but similar warm ischemia; shorter hospital stay; clinically acceptable renal function. |
| Khajeh et al., 2023 | Netherlands | Retrospective cohort | Living kidney donors | Robot-assisted DN vs LDN | Safe implementation by experienced laparoscopic surgeons; equivalent or non-inferior perioperative and renal outcomes. |
| Van de Geijn et al., 2024 | Italy | Retrospective bicentric | Living kidney donors | RDN vs LDN | Faster learning curve and improved multi-vessel handling; infrequent complications; comparable outcomes. |
| Hinojosa-Gonzalez et al., 2023 | Mexico/International | Systematic review with meta-analysis | Living donors | RDN vs LDN | Similar operative time and bleeding; slightly longer warm ischemia for RDN; reduced stay and pain; equivalent complications. |
| Munoz Abraham et al., 2025 | International | Review/update | Living donors | RDN focus | Low complication rates, reliable perioperative outcomes, ergonomic and precision advantages, maintained donor and recipient safety. |
| Centonze et al., 2023 | Italy | Retrospective bicentric cohort | Living kidney donors | RDN vs LDN | Faster learning curve and improved handling of multiple vessels; low comparable complications. |
| Pham et al., 2026 | Vietnam | Retrospective observational | Living donors | Right robotic-assisted laparoscopic DN | Mean operative time about 172 minutes, minimal blood loss, no intraoperative complications or open conversion, satisfactory early renal outcomes. |
| Kourounis et al., 2024 | International | Cochrane review | Live kidney donors | RDN vs LDN/ODN | Comparable pain and complications; longer procedure but possible advantages in selected outcomes; supports minimally invasive equivalence. |
| Bhattu et al., 2015 | India | Prospective randomized comparative | Living donors | Robotic vs standard LDN | Lower pain and analgesic requirements and shorter stay with RDN; longer operative and warm ischemia times; similar complications and graft outcomes. |
Synthesis and Interpretation of Findings
Both RDN and LDN generally produced comparable donor-centered outcomes. Postoperative eGFR and serum creatinine remained clinically acceptable after both procedures, and major complications, conversions, and adverse donor events were uncommon. Several studies found modestly shorter hospitalization and lower early postoperative pain with RDN, but these benefits were not uniform. RDN often required longer operative time during early implementation, reflecting robotic setup and learning-curve effects; thus, current findings do not establish overall clinical superiority.
Critical Evaluation of Evidence Quality and Heterogeneity
The consistency of donor safety findings supports the feasibility of both techniques in experienced centers. However, most evidence came from non-randomized retrospective cohorts with variable sample sizes. Differences in institutional robotic volume, procedural standardization, training infrastructure, and surgeon experience strongly influenced operative efficiency and complication reporting. Results from highly specialized centers should therefore be generalized cautiously.
Comparative Perspectives Across Geographic and Institutional Settings
Studies from Europe, Asia, and Latin America consistently reported acceptable renal outcomes and low complication rates when appropriate expertise was available. Yet access to robotic technology, training pathways, maintenance resources, and sustainable case volumes varied substantially. Adoption is therefore both a surgical and a healthcare-management decision involving institutional capacity, resource allocation, and economic feasibility.
Management and Social Implications
Robotic surgery may offer ergonomic benefits and incremental improvements in early recovery, but evidence does not support universal implementation. Potential reductions in hospitalization and analgesic use must be balanced against acquisition, maintenance, staffing, and training costs. Unequal access to robotic platforms may widen disparities between transplant centers; future evaluation should address accessibility, institutional equity, and sustainability alongside clinical outcomes.
Limitations and Future Research Directions
The evidence base was dominated by retrospective observational studies, heterogeneous outcome definitions, varying perioperative protocols, and short follow-up. Narrative synthesis precluded pooled effect estimates. Cost-effectiveness, donor quality of life, long-term renal function, and healthcare utilization remain insufficiently studied. Future research should use multicenter prospective or randomized designs, standardized outcomes, longer follow-up, learning-curve evaluation, and comprehensive health-economic analysis.
Summary of Key Findings
Both RDN and LDN are safe and clinically effective minimally invasive options. Preservation of renal function and low complication rates are the most consistent findings. Potential robotic benefits in recovery and ergonomics appear incremental and context dependent, supporting cautious integration rather than replacement of established laparoscopic approaches.
| No. | Category | Key Research Outcomes | References |
|---|---|---|---|
| 1 | Renal Function Preservation | Comparable postoperative eGFR and serum creatinine between RDN and LDN. | Grigoriou et al., 2025; Hinojosa-Gonzalez et al., 2023; Khajeh et al., 2023; Kourounis et al., 2024; Zeuschner et al., 2020 |
| 2 | Operative Time and Learning Curve | RDN frequently had longer operative duration during early implementation. | Van de Geijn et al., 2024; Windisch et al., 2022 |
| 3 | Hospital Stay and Recovery | Several studies reported shorter hospitalization and lower postoperative pain with RDN. | Bhattu et al., 2015; Hinojosa-Gonzalez et al., 2023 |
| 4 | Complication Rates | Low and generally comparable complication and conversion rates. | Centonze et al., 2023; Pham et al., 2026 |
| 5 | Technical and Institutional Factors | Outcomes were influenced by surgeon experience, institutional volume, and learning-curve maturity. | Khajeh et al., 2023; Van de Geijn et al., 2024 |
| 6 | Management and Resource Implications | Implementation requires consideration of cost, infrastructure, training, and sustainability. | Munoz Abraham et al., 2025; Musquera et al., 2025; Serni et al., 2021; Shen et al., 2020 |
Conclusion
This systematic review indicates that RDN and LDN demonstrate generally comparable donor-centered clinical outcomes, particularly postoperative renal function preservation and perioperative safety. Both techniques were associated with stable eGFR, acceptable serum creatinine, and low major complication rates. Modest reductions in hospital stay and early pain were reported in some robotic cohorts but were not uniform.
Operative duration in RDN is strongly influenced by institutional learning curves and surgeon experience. High-volume centers reported progressive improvement after approximately 20–40 cases, suggesting that implementation maturity rather than inherent procedural superiority explains many observed differences.
The review contributes an updated donor-centered perspective based on evidence from 2010–2025. Broader robotic adoption should be guided by institutional case volume, surgeon proficiency, infrastructure, economic sustainability, and learning capacity. Current evidence does not establish clear long-term superiority over laparoscopy.
Future studies should prioritize multicenter prospective and randomized comparisons, standardized outcome reporting, consistent complication grading, longer follow-up, cost-effectiveness and cost–utility analysis, donor quality of life, functional recovery, and long-term graft outcomes.
Author Contributions
Muhammad Rizki Fadil led conceptualization, protocol development, literature searching, data extraction and analysis, and manuscript drafting and revision. Fabian Gamal Sutrisno contributed to screening, quality appraisal, and methodological review. Jeremia Yusak Lestari contributed to data extraction, table preparation, and interpretation. Archie Fontana Iskandar supported critical evidence analysis, discussion and managerial implications, and narrative consistency. All authors reviewed and approved the final manuscript.
Acknowledgements
The authors thank the Director and management of RSUD Cimacan, Cianjur Regency, West Java, for institutional support, flexibility, and guidance, and acknowledge colleagues in the Department of Surgery and the kidney transplant service team for clinical insights, moral support, and collaboration.
References
Bhattu, A. S., Ganpule, A., Sabnis, R. B., Murali, V., Mishra, S., & Desai, M. (2015). Robot-assisted laparoscopic donor nephrectomy vs standard laparoscopic donor nephrectomy: A prospective randomized comparative study. Journal of Endourology, 29(12), 1334–1340. https://doi.org/10.1089/end.2015.0213
Boyar, K., Pham, A., Swantek, S., Ward, G., & Herman, G. (2021). Laboratory Information Management Systems (LIMS). In Cannabis Laboratory Fundamentals (pp. 131–151). Springer. https://doi.org/10.1007/978-3-030-62716-4_7
Calpin, G. G., Hehir, C., Davey, M. G., MacCurtain, B. M., Little, D., & Davis, N. F. (2025). Right and left living donor nephrectomy and operative approach: A systematic review and meta-analysis of donor and recipient outcomes. Transplantation Reviews, 39(1), 100880. https://doi.org/10.1016/j.trre.2024.100880
Centonze, A., Popolo, R., Panagou, C., Macbeth, A., & Dimaggio, G. (2023). Experiential techniques and therapeutic relationship in the treatment of narcissistic personality disorder: The case of Laura. Journal of Clinical Psychology, 79, 1656–1669. https://doi.org/10.1002/jclp.23514
Chan, L. W., Irish, G. L., Goh, T. L., et al. (2025). Outcomes of living kidney donors following donor nephrectomy in Aotearoa New Zealand. Kidney International Reports, 10(3), 762–771. https://doi.org/10.1016/j.ekir.2024.11.1362
Coco, D., & Leanza, V. (2025). Systematic review of robotic nephrectomy for kidney cancer. Journal of Kidney Cancer and VHL, 12(1), 29–35. https://doi.org/10.15586/jkc.v12i1.372
Dagnæs-Hansen, J., Kristensen, G. H., Rohrsted, M., Sørensen, S. S., & Røder, A. (2025). Early and late surgical complications following living donor nephrectomy. Scandinavian Journal of Urology, 60, 83–89. https://doi.org/10.2340/sju.v60.43346
Dagnæs-Hansen, J., Kristensen, G. H., Stroomberg, H. V., Sørensen, S. S., & Røder, A. (2022). Surgical approaches and outcomes in living donor nephrectomy: A systematic review and meta-analysis. European Urology Focus, 8(6), 1795–1801. https://doi.org/10.1016/j.euf.2022.03.021
Drukker, M., Weltens, I., van Hooijdonk, C. F. M., Vandenberk, E., & Bak, M. (2021). Development of a methodological quality criteria list for observational studies. Frontiers in Research Metrics and Analytics, 6, 675071. https://doi.org/10.3389/frma.2021.675071
Hinojosa-Gonzalez, D. E., et al. (2023). Robotic-assisted versus laparoscopic living donor nephrectomy for renal transplantation: A systematic review and meta-analysis. Annals of the Royal College of Surgeons of England, 105(1), 7–13. https://doi.org/10.1308/rcsann.2021.0357
Kędzierska-Kapuza, K., et al. (2024). Robotic-assisted nephrectomy for living kidney donation—single center initial experience and review. Journal of Clinical Medicine, 13(13), 3754. https://doi.org/10.3390/jcm13133754
Khajeh, E., et al. (2023). Robot-assisted versus laparoscopic living donor nephrectomy: Superior outcomes after completion of the learning curve. Journal of Robotic Surgery, 17(6), 2513–2526. https://doi.org/10.1007/s11701-023-01681-0
Kourounis, G., et al. (2024). Robotic versus laparoscopic versus open nephrectomy for live kidney donors. Cochrane Database of Systematic Reviews, (5), CD006124. https://doi.org/10.1002/14651858.CD006124.pub3
Mamikutty, R., Aly, A. S., & Marhazlinda, J. (2021). Selecting risk of bias tools for observational studies. International Journal of Environmental Research and Public Health, 18(16), 8623. https://doi.org/10.3390/ijerph18168623
Matas, A. J., & Rule, A. D. (2022). Long-term medical outcomes of living kidney donors. Mayo Clinic Proceedings, 97(11), 2107–2122. https://doi.org/10.1016/j.mayocp.2022.06.013
Munoz Abraham, A. S., Morsi, M., & Vianna, R. (2025). Robotic assisted laparoscopic donor nephrectomy: An update. Current Urology Reports, 26(6), 35. https://doi.org/10.1007/s11934-025-01263-7
Musquera, M., et al. (2025). Living-donor kidney transplantation: Comparison of robotic-assisted versus conventional open technique. Transplant International, 38, 14953. https://doi.org/10.3389/ti.2025.14953
Napoli, N., et al. (2024). Safety and safety protocols for living donor nephrectomy in Italy. Updates in Surgery, 76(1), 209–218. https://doi.org/10.1007/s13304-023-01678-2
Ortiz, F., et al. (2025). Evaluating risk in kidney living donors. Transplant International, 38, 14024. https://doi.org/10.3389/ti.2025.14024
Pham, D. M., Truong, H. T. T., Le, H. T., Chuan, H. K., & Thai, M. S. (2026). Right robotic-assisted laparoscopic living donor nephrectomy: Initial results. Clinical Transplantation and Research. https://doi.org/10.4285/ctr.25.0064
Plage, H., et al. (2020). Extended criteria donors in living kidney transplantation. Therapeutics and Clinical Risk Management, 16, 1033–1044. https://doi.org/10.2147/TCRM.S267924
Serni, S., et al. (2021). Robot-assisted laparoscopic living donor nephrectomy: The University of Florence technique. Frontiers in Surgery, 7, 588215. https://doi.org/10.3389/fsurg.2020.588215
Shen, C., et al. (2020). Factors associated with hospital decisions to purchase robotic surgical systems. MDM Policy and Practice, 5(1). https://doi.org/10.1177/2381468320904364
Van de Geijn, E. F., et al. (2024). Effective and safe implementation of robot-assisted donor nephrectomy by experienced laparoscopic surgeons. World Journal of Surgery, 48(8). https://doi.org/10.1002/wjs.12249
Wang, L., et al. (2020). Long-term outcomes of laparoscopic versus open donor nephrectomy for kidney transplantation: A meta-analysis. American Journal of Translational Research, 12(10), 5993–6002.
Windisch, O. L., et al. (2022). Robotic versus hand-assisted laparoscopic living donor nephrectomy. Journal of Robotic Surgery, 16(6), 1471–1481. https://doi.org/10.1007/s11701-022-01393-2
Xun, Y., et al. (2023). Characteristics of the sources, evaluation, and grading of certainty of evidence in systematic reviews in public health. Frontiers in Public Health, 11, 998588. https://doi.org/10.3389/fpubh.2023.998588
Zaytoun, O., et al. (2021). Laparoscopic donor nephrectomy: Technique and outcome, a single-center experience. African Journal of Urology, 27, 151. https://doi.org/10.1186/s12301-021-00254-7
Zeuschner, P., et al. (2020). Robot-assisted versus laparoscopic donor nephrectomy: A comparison of 250 cases. Journal of Clinical Medicine, 9(6), 1610. https://doi.org/10.3390/jcm9061610